Acorah Software Products - Accounts Production16.6.950falsetruefalsetrueNo description of principal activity17 March 202431 March 202531 March 202515570133Mr Abdulla Choudhuryiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure155701332024-03-16155701332025-03-31155701332024-03-172025-03-3115570133frs-bus:PrivateLimitedCompanyLtd2024-03-172025-03-3115570133frs-bus:FilletedAccounts2024-03-172025-03-3115570133frs-bus:Micro-entities2024-03-172025-03-3115570133frs-bus:AuditExempt-NoAccountantsReport2024-03-172025-03-3115570133frs-bus:Director12024-03-172025-03-31
Registered number: 15570133
Meadow View Pharma Consultancy Ltd
Financial Statements
For the Period 17 March 2024 to 31 March 2025
Meadow View Pharma Consultancy Ltd
Balance Sheet
As At 31 March 2025
Balance Sheet
Registered number: 15570133
31 March 2025
£
Current assets
323
NET CURRENT ASSETS
323
TOTAL ASSETS LESS CURRENT LIABILITIES
323
Accruals and deferred income
(300)
NET ASSETS
23
CAPITAL AND RESERVES
23
Notes
1.General Information
Meadow View Pharma Consultancy Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15570133. The registered office is 31 Green Lane, Ockbrook, Derby, DE72 3SE.
2.Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.